Syphilitic meningitis

disease
On this page

Also known as meningeal syphilismeningitis, syphiliticsyphilitic aseptic meningitisTreponema caused infectious meningitisTreponema infectious meningitis

Summary

Syphilitic meningitis (MONDO:0000936) is a disease. A subtype of Treponema infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namesyphilitic meningitis
Mondo IDMONDO:0000936
MeSHC536775
DOIDDOID:10073
SNOMED CT301086002
UMLSC0153166
MedGen57546
GARD0008731
Is cancer (heuristic)no

Also known as: meningeal syphilis · meningitis, syphilitic · syphilitic aseptic meningitis · Treponema caused infectious meningitis · Treponema infectious meningitis

Disease family

This is a subtype of Treponema infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious diseasebacterial infectious diseasebacterial sexually transmitted diseaseTreponema infectious diseasesyphilitic meningitis

Related subtypes (3): syphilitic encephalitis, pinta disease, syphilis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.